Kings Path Partners LLC Makes New Investment in BioLife Solutions, Inc. $BLFS

Kings Path Partners LLC bought a new stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 16,570 shares of the medical equipment provider’s stock, valued at approximately $644,000.

Other large investors have also recently made changes to their positions in the company. State of Wyoming bought a new stake in shares of BioLife Solutions during the 1st quarter worth $52,000. Nisa Investment Advisors LLC grew its position in BioLife Solutions by 13.3% during the third quarter. Nisa Investment Advisors LLC now owns 2,209 shares of the medical equipment provider’s stock valued at $86,000 after buying an additional 260 shares during the period. WINTON GROUP Ltd purchased a new stake in BioLife Solutions during the second quarter worth about $201,000. AXQ Capital LP purchased a new stake in BioLife Solutions during the second quarter worth about $203,000. Finally, Cetera Investment Advisers increased its holdings in BioLife Solutions by 26.8% during the first quarter. Cetera Investment Advisers now owns 11,614 shares of the medical equipment provider’s stock worth $222,000 after buying an additional 2,458 shares during the last quarter. 93.24% of the stock is owned by hedge funds and other institutional investors.

BioLife Solutions Price Performance

Shares of NASDAQ:BLFS opened at $38.61 on Thursday. The firm has a market capitalization of $1.89 billion, a PE ratio of 33.28 and a beta of 1.82. BioLife Solutions, Inc. has a twelve month low of $17.86 and a twelve month high of $39.76. The company has a 50-day moving average price of $37.11 and a two-hundred day moving average price of $29.86.

BioLife Solutions (NASDAQ:BLFS) last posted its earnings results on Thursday, August 6th. The medical equipment provider reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.88. The firm had revenue of $28.47 million during the quarter, compared to the consensus estimate of $27.80 million. BioLife Solutions had a net margin of 53.29% and a return on equity of 2.70%. Analysts anticipate that BioLife Solutions, Inc. will post 0.03 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. TD Cowen cut shares of BioLife Solutions from a “buy” rating to a “hold” rating and dropped their target price for the company from $33.00 to $31.00 in a research note on Wednesday, July 22nd. Wall Street Zen downgraded shares of BioLife Solutions from a “buy” rating to a “hold” rating in a research report on Saturday, July 25th. HC Wainwright downgraded shares of BioLife Solutions from a “buy” rating to a “neutral” rating and reduced their target price for the company from $32.00 to $31.00 in a research report on Thursday, July 23rd. Jefferies Financial Group lowered shares of BioLife Solutions from a “buy” rating to a “hold” rating and raised their price target for the stock from $30.00 to $31.00 in a research note on Thursday, July 23rd. Finally, Weiss Ratings raised shares of BioLife Solutions from a “sell (d-)” rating to a “hold (c)” rating in a report on Tuesday, September 22nd. One investment analyst has rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $31.38.

BioLife Solutions Profile

BioLife Solutions, Inc develops and supplies products and services used to preserve, process, store and transport biological materials. Its solutions support the development and manufacture of cell and gene therapies, including products designed to help maintain the viability and functionality of cells, tissues and other biologic materials throughout the bioprocessing workflow.

The company’s portfolio includes preservation media such as CryoStor and HypoThermosol, cell thawing and handling products, and related storage and shipping systems.